| Literature DB >> 24800239 |
Hong Zheng1, Christian C Yde1, Karina Arnberg2, Christian Mølgaard2, Kim F Michaelsen2, Anni Larnkjær2, Hanne C Bertram1.
Abstract
The plasma and urine metabolome of 192 overweight 12-15-year-old adolescents (BMI of 25.4 ± 2.3 kg/m(2)) were examined in order to elucidate gender, pubertal development measured as Tanner stage, physical activity measured as number of steps taken daily, and intra-/interindividual differences affecting the metabolome detected by proton NMR spectroscopy. Higher urinary excretion of citrate, creatinine, hippurate, and phenylacetylglutamine and higher plasma level of phosphatidylcholine and unsaturated lipid were found for girls compared with boys. The results suggest that gender differences in the metabolome are being commenced already in childhood. The relationship between Tanner stage and the metabolome showed that pubertal development stage was positively related to urinary creatinine excretion and negatively related to urinary citrate content. No relations between physical activity and the metabolome could be identified. The present study for the first time provides comprehensive information about associations between the metabolome and gender, pubertal development, and physical activity in overweight adolescents, which is an important subject group to approach in the prevention of obesity and life-style related diseases. While this study is preliminary, these results may have the potential to translate into clinical applicability upon further investigations; if biomarkers for Tanner stage can be established, these might be used for identification of individuals susceptible to an early pubertal development.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24800239 PMCID: PMC3985195 DOI: 10.1155/2014/537157
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Intrasubject variation in the urine and plasma metabolome of adolescents over a 12-week interval: (a) PCA score plot of urine samples from boys (PC1 explains 28.3% and PC2 explains 16.4% of the variation); (b) PCA score plot of plasma samples from boys (PC1 explains 64.3% and PC2 explains 14.4% of the variation); (c) PCA score plot of urine samples from girls (PC1 explains 24.3% of the variation and PC2 explains 10.2% of the variation); (d) PCA score plot of plasma samples from girls (PC1 explains 55.7% and PC2 explains 11.6% of the variation); (e) PC1 loadings of urine samples; (f) PC1 loadings of plasma samples. The same subject is indicated by the same color in PCA score plots and the arrow points from week 0 to week 12. Assignments: 1: creatinine (3.04 and 4.05 ppm); 2: urea (5.50–6.10 ppm); 3: hippurate (3.96, 7.54, and 7.82 ppm); 4: lipids; 5: glucose.
Figure 2Gender difference (●: boys; ▲: girls) in the urine and plasma metabolome of adolescents: (a) PCA score plot of urine samples (PC1 explains 20.3% and PC3 explains 5.4% of the variation); (b) PCA score plot of plasma samples (PC1 explains 59.2% and PC6 explains 2.3% of the variation); (c) OPLS-DA score plot of urine samples (1 predictive and 2 orthogonal components; R 2 X = 32.8%; R 2 Y = 50.4%; Q 2 = 28.3%; P < 0.0001); (d) OPLS-DA score plot of plasma samples (1 predictive and 3 orthogonal components; R 2 X = 73.8%; R 2 Y = 46.4%; Q 2 = 26.5%; P < 0.0001); (e) S-line plot of urine samples; (f) S-line plot of plasma samples. Assignments: 1: citrate (2.53, 2.56, 2.67, and 2.70 ppm); 2: creatinine (3.04 and 4.05 ppm); 3: urea (5.50–6.10 ppm); 4: lipoproteins (0.84 and 1.26 ppm); 5: choline (3.20 ppm); 6: phosphocholine (3.22 ppm); 7: unsaturated lipids (5.29 ppm).
Mixed models of Tanner stage and gender effects in overweight adolescents on urinary metabolitesa.
|
| Citrate | Creatinine | Hippurate | Phenylacetylglutamine | Urea | ||
|---|---|---|---|---|---|---|---|
| Gender | ♂ | 70 | 27.1 ± 2.4b | 262.9 ± 5.1b | 46.6 ± 3.5b | 38.9 ± 2.4 | 1358.2 ± 48.4a |
| ♀ | 115 | 36.4 ± 2.7a | 280.0 ± 5.4a | 57.1 ± 3.9a | 45.4 ± 2.6 | 1087.3 ± 53.5b | |
|
| |||||||
| Tanner stage | 1 | ♂: 5; ♀: 2 | 49.2 ± 6.8a | 262.8 ± 12.6b | 39.6 ± 9.0 | 33.7 ± 6.1 | 1326.5 ± 124.0 |
| 2 | ♂: 30; ♀: 7 | 29.7 ± 2.5bc | 262.3 ± 6.9b | 57.0 ± 5.0 | 41.2 ± 3.3 | 1211.8 ± 67.9 | |
| 3 | ♂: 18; ♀: 53 | 30.8 ± 1.7b | 257.7 ± 4.3b | 57.4 ± 3.0 | 47.5 ± 2.2 | 1256.6 ± 43.1 | |
| 4 | ♂: 13; ♀: 43 | 25.1 ± 1.9c | 270.4 ± 6.6b | 56.6 ± 3.8 | 48.3 ± 2.6 | 1257.8 ± 54.7 | |
| 5 | ♂: 4; ♀: 10 | 24.1 ± 4.6bc | 303.8 ± 8.9a | 48.5 ± 6.4 | 40.0 ± 4.3 | 1060.9 ± 87.7 | |
|
| |||||||
| Significant effects ( | Gc |
|
|
| 0.07 |
| |
| Td |
|
| 0.30 | 0.06 | 0.29 | ||
| G ∗ T | 0.24 | 0.81 | 0.73 |
|
| ||
aValues are the relative concentrations according to a known TSP concentration and expressed mean ± SE; bNumber of subjects (♂: boys; ♀: girls); cGender; dTanner stages; Different letters indicate significant differences within columns (P < 0.05).
Figure 3(a) PCA score plot of boys (PC1 explains 21.4% and PC3 explains 6.3% of the variation); (b) PCA score plot of girls (PC1 explains 19.7% and PC4 explains 5.9% of the variation) obtained for the urine metabolome of adolescents and showing Tanner stage (▲: stage 1; ♦: stage 2; ●: stage 3; ★: stage 4; ▼: stage 5). (c) PLSR prediction plot of Tanner stage in boys (the optimal number of PLSs = 2; R 2 X = 27.1%; R 2 Y = 51.9%; Q 2 = 25.5%; P < 0.001); (d) PLSR prediction plot of Tanner stage in girls (the optimal number of PLSs = 4; R 2 X = 37.3%; R 2 Y = 69.4%; Q 2 = 24.6%; P < 0.0001); (e) PLS1 loadings of boys; (f) PLS1 loadings of girls. Assignments: 1: citrate (2.53, 2.56, 2.67, and 2.70 ppm); 2: creatinine (3.04 and 4.05 ppm); 3: hippurate (3.96, 7.54 and 7.82 ppm); 4: phenylacetylglutamine (7.35 ppm).